Posted Tue, May, 08,2012
Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Translational Oncogenomics.
One of the ways we measure an article's visibility is the number of views and downloads it receives. The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal's visibility figure.
Counting views and downloads is complicated by the possibility of fraud and automated views by search engines. To ensure that readers and authors can have confidence in our visibility analytics we have now formally joined Project Counter. Release 3 of Project Counter's code of practice addresses these and other problems.
Translational Oncogenomics' membership of Project Counter ensures that readers and authors can trust its visibility analytics.
Visit this page to see the latest visibility information for Translational Oncogenomics.
Fri 24 May, 2013Article Usage Metrics Now Available for all Journals
Fri 24 May, 2013Treatment of Recurrent HNSCC
Fri 24 May, 2013Bilateral Renal Infarction in a Lupus Patient
I would like to congratulate Clinical Medicine Insights: Endocrinology and Diabetes for the professional way it manages the entire publication process. I am certain it will have a bright future, and reach top positions among endocrine and metabolic journals.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)